產(chǎn)品基本信息
產(chǎn)品編號(hào):D689963
產(chǎn)品名稱(chēng):L-threo-Droxidopa-13C6
產(chǎn)品CAS:
規(guī)格含量:1mg
產(chǎn)品價(jià)格:面議
聯(lián)系我們:
產(chǎn)品詳細(xì)介紹
標(biāo)準(zhǔn)品編號(hào):
D689963
名稱(chēng):
L-threo-Droxidopa-13C6
別名:
(βR)-β,3-Dihydroxy-L-tyrosine- 13C; threo-β,3-Dihydroxy-L-tyrosine- 13C; L-threo-3-(3,4-Dihydroxyphenyl)serine- 13C; (-)-threo-3,4-Dihydroxyphenylserine-13C; (2S,3R)-3-(3,4-Dihydroxyphenyl)-2-amino-3-hydroxypropanoic Acid- 13C; DOPS- 13C; L-DOPS- 13C; L-Threodops- 13C; L-threo-3,4-Dihydroxyphenylserine- 13C; threo-Dopaserine- 13C;
參考CAS:
23651-95-8
分子式:
C?¹³C?H??NO?
分子量:
219.14
種類(lèi):
Building Blocks; Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
Droxidopa-13C6 is a labeled compound of L-threo-Droxidopa (D689960) which is a synthetic amino acid precursor of Norepinephrine (N674500). Antiparkinsonian.
參考文獻(xiàn)
Bartholini, J., et al.: J. Pharmacol. Exp. Ther ., 193, 523 (1975), Kato, T., et al.: Biochem. Pharmacol., 36, 3051 (1987), Kawabata, A., et al.: Br J. Pharmacol., 111, 503 (1994),